-- The latest market report published by Credence Research, Inc. "Global Joint Pain Injections Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026," the global joint pain injection market was valued at US$2.146.0 million in 2017 and is expected to reach US$4.888.5 million by 2026, expanding at a CAGR of 9.7% from 2018 to 2026.
According to the World Health Organization (WHO) research findings, approximately 150 diseases and syndromes are classified as musculoskeletal disorder. It has a huge negative impact on the patients ' socio-economic aspect. Bioventus got approval for its product Durolane in 2017 for treating knee osteoarthritis, similarly Flexion Therapeutics, Inc., received FDA approval in 2017 for its product Zilretta to overcome pain associated with osteoarthritis Hyaluronic acid injections are reigning the injection segment for joint pain injections market. Its inherent properties, such as excellent lubrication and shock absorbing properties, drastically reduce joint stiffness and tenderness in patients with osteoarthritis. Because of its anti-inflammatory properties, corticosteroid injections are used as adjuvant medications to provide short-term relief in athletes experiencing joint sprains.
Don't miss out on business opportunities in Joint Pain Injections Market
Contact Us For Customization in Type, Application & Region: https://www.credenceresearch.com/request-for-customization/59663
Knee and ankle joints are dominating the joint pain injections market. Significant rise in tenosynovitis and prolonged physical activity drive the market growth for ankle and knee joints. Rampant growth in production industry and increasing competition among athletes together bolster the market growth. Shoulder and elbow joint will gain huge revenue in the coming years on account of increasing utilization of electronic gadgets such as mobile phones, laptops and personal computer. Rising prevalence of rotator cuff injury further consolidate the shoulder and elbow joints market growth.
With a share of 34 percent, North America is leading the market for joint pain injections in the regional segment. The main parameters responsible for its excellent market growth are the increasing prevalence of obesity and high acceptance of viscosupplementation in the treatment of joint pains. The existence of pioneers such as Allergan, Inc., Sanofi S.A., Pfizer, Inc., etc. provides positive impetus to the growth of the market for joint pain injections in the North American region.
Europe is in second position accounting for a share of 28% owing to the rising prevalence of osteoarthritis in geriatric population. Affordable reimbursement scenario further propel the market growth in Europe region. Asia Pacific represents 20% market share on account of increasing number of trauma and accident cases and rising prevalence of musculoskeletal disorders.
Pharmaceutical companies pioneering in the joint pain injections market are
Allergan, Plc.,
Anika Therapeutics, Inc.,
Bioventus LLC.,
Chugai Pharmaceutical Co., Ltd.,
Flexion Therapeutics, Inc.,
Ferring B.V.,
Pfizer, Inc.,
Sanofi S.A.,
SEIKAGAKU Corporation
Zimmer Biomet Holdings, Inc.
Key Market Movements:
Rising prevalence of osteoarthritis and rheumatoid arthritis in geriatric population worldwide
Increasing demand for hyaluronic acid injections over other surgical procedures to overcome joint pain
Affordable reimbursement scenario associated with joint pain injections
Get Sample(Free) @ https://www.credenceresearch.com/sample-request/59663
ToC:
Chapter 1. Preface
..........
Chapter 2. Executive Summary
............
Chapter 3. Joint Pain Injections Market: Dynamics and Future Outlook
............
Chapter 4. Global Joint Pain Injections Market, by Injection
4.1. Overview
4.2. Hyaluronic Acid Injections
4.3. Corticosteroid Injections
4.4. Others
Chapter 5. Global Joint Pain Injections Market, by Joint
5.1. Overview
5.2. Hip Joint
5.3. Knee & Ankle
5.4. Shoulder & Elbow
5.5. Facet Joints of the Spine
5.6. Others
Chapter 6. Global Joint Pain Injections Market, by Geography
..............
Chapter 7. Company Profiles
7.1. Allergan, Plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Anika Therapeutics, Inc.
7.3. Bioventus LLC
7.4. Chugai Pharmaceutical Co., Ltd.
7.5. Flexion Therapeutics, Inc.
7.6. Ferring B.V.
7.7. Pfizer, Inc.
7.8. Sanofi S.A.
7.9. SEIKAGAKU Corporation
7.10. Zimmer Biomet Holdings, Inc.
............... toc Continued
Browse the full report Joint Pain Injections Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/joint-pain-injections-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals. Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
Related Report:
Global Calcitonin Injection Market Insights, Forecast to 2025
Global Osteoarthritis Pain Solution Market Research Report 2019
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com
Release ID: 502052
Google
RSS